FTV · News · 20260808N
Guidance / Outlook
Fortive Corp · 2026-08-08 · Importance 51 · Surprise 60 · In source text
Fortive raised its full-year 2026 adjusted EPS guidance to $2.95–$3.05 following second-quarter results, according to third-party reporting. The outlook reflects accelerated organic growth, wider adjusted EBITDA margins, and stronger cash conversion across Intelligent Operating Solutions and Advanced Healthcare Solutions. Reported constraints include healthcare mix, tariffs, and uneven hospital spending, which could limit the pace of improvement during the remainder of 2026.
Key facts
- Fortive issued full-year 2026 EPS guidance of $2.95–$3.05. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | Fortive issued full-year 2026 EPS guidance of $2.95–$3.05. |